Lutz Binder

4.7k total citations · 1 hit paper
86 papers, 3.3k citations indexed

About

Lutz Binder is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Lutz Binder has authored 86 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 15 papers in Molecular Biology and 15 papers in Epidemiology. Recurrent topics in Lutz Binder's work include Heart Failure Treatment and Management (20 papers), Cardiovascular Function and Risk Factors (14 papers) and Cardiac Health and Mental Health (8 papers). Lutz Binder is often cited by papers focused on Heart Failure Treatment and Management (20 papers), Cardiovascular Function and Risk Factors (14 papers) and Cardiac Health and Mental Health (8 papers). Lutz Binder collaborates with scholars based in Germany, Austria and United States. Lutz Binder's co-authors include Burkert Pieske, Rolf Wachter, Stavros Konstantinides, Annette Geibel, Manfred Olschewski, Christoph Herrmann‐Lingen, Gerd Hasenfuß, Frank Edelmann, Götz Gelbrich and Claudia R. Binder and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Molecular and Cellular Biology.

In The Last Decade

Lutz Binder

82 papers receiving 3.2k citations

Hit Papers

Exercise Training Improves Exercise Capacity and Diastoli... 2011 2026 2016 2021 2011 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lutz Binder Germany 31 1.8k 604 569 393 303 86 3.3k
Luigina Guasti Italy 31 1.5k 0.8× 302 0.5× 396 0.7× 380 1.0× 465 1.5× 145 3.1k
Zhimin Wang China 24 1.2k 0.6× 273 0.5× 1.1k 1.9× 444 1.1× 318 1.0× 127 3.0k
Xin Zhao China 32 1.4k 0.8× 535 0.9× 1.7k 3.0× 583 1.5× 539 1.8× 135 4.5k
Vincenzo Russo Italy 31 2.5k 1.4× 472 0.8× 258 0.5× 423 1.1× 730 2.4× 315 4.0k
Giulia Renda Italy 27 1.9k 1.1× 350 0.6× 600 1.1× 539 1.4× 746 2.5× 111 3.5k
Panagiotis Korantzopoulos Greece 37 3.4k 1.9× 326 0.5× 418 0.7× 618 1.6× 641 2.1× 202 4.8k
Alessandro Di Minno Italy 31 737 0.4× 318 0.5× 379 0.7× 580 1.5× 453 1.5× 125 3.0k
Spyridon Deftereos Greece 30 2.1k 1.2× 150 0.2× 419 0.7× 903 2.3× 561 1.9× 162 3.6k
Suma Konety United States 28 2.9k 1.6× 111 0.2× 311 0.5× 296 0.8× 424 1.4× 77 3.9k
Antonio Muscari Italy 28 698 0.4× 164 0.3× 686 1.2× 474 1.2× 398 1.3× 88 2.8k

Countries citing papers authored by Lutz Binder

Since Specialization
Citations

This map shows the geographic impact of Lutz Binder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lutz Binder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lutz Binder more than expected).

Fields of papers citing papers by Lutz Binder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lutz Binder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lutz Binder. The network helps show where Lutz Binder may publish in the future.

Co-authorship network of co-authors of Lutz Binder

This figure shows the co-authorship network connecting the top 25 collaborators of Lutz Binder. A scholar is included among the top collaborators of Lutz Binder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lutz Binder. Lutz Binder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michaelis, Sophie, et al.. (2022). Case report: Major depression and Therapeutic Drug Monitoring in patient with CYP2C19 genetic polymorphism. Pharmacopsychiatry. 55(3). 163–163.
2.
Schnelle, Moritz, Andreas Leha, Tobias Daniel Trippel, et al.. (2021). Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial. Cells. 10(10). 2796–2796. 3 indexed citations
3.
Trippel, Tobias Daniel, Meinhard Mende, Hans‐Dirk Düngen, et al.. (2021). The Diagnostic and Prognostic Value of Galectin-3 in Patients at Risk for Heart Failure with Preserved Ejection Fraction: Results from the DIAST-CHF Study. ESC Heart Failure. 8(2). 829–841. 32 indexed citations
4.
Nagel, Jonas, Mira‐Lynn Chavanon, Lutz Binder, et al.. (2021). How family history of premature myocardial infarction affects patients at cardiovascular risk.. Health Psychology. 40(11). 754–763. 1 indexed citations
5.
Sadlonova, Monika, Thomas Meyer, Lutz Binder, et al.. (2020). Higher galectin-3 levels are independently associated with lower anxiety in patients with risk factors for heart failure. BioPsychoSocial Medicine. 14(1). 24–24. 1 indexed citations
6.
Ahsen, Nicolas von, et al.. (2018). Macro-CK type 2 in metastatic prostate cancer. Diagnosis. 6(3). 307–309. 3 indexed citations
7.
Stahrenberg, Raoul, André Duvinage, Meinhard Mende, et al.. (2015). Determinants of Submaximal Exercise Capacity in Patients at Risk for Heart Failure with Preserved Ejection Fraction—results from the DIAST-CHF Study. ESC Heart Failure. 2(2). 76–84. 7 indexed citations
8.
Lüers, Claus, et al.. (2013). NT-proANP and NT-proBNP as prognostic markers in patients with acute decompensated heart failure of different etiologies. Clinical Biochemistry. 46(12). 1013–1019. 15 indexed citations
9.
Streit, Frank, Lutz Binder, Gunnar Brandhorst, et al.. (2011). Use of Total and Unbound Imatinib and Metabolite LC-MS/MS Assay to Understand Individual Responses in CML and GIST Patients. Therapeutic Drug Monitoring. 33(5). 632–643. 21 indexed citations
10.
Stahrenberg, Raoul, Frank Edelmann, Meinhard Mende, et al.. (2010). The Novel Biomarker Growth Differentiation Factor 15 in Heart Failure with Normal Ejection Fraction. European Journal of Heart Failure. 12(12). 1309–1316. 121 indexed citations
12.
Lüers, Claus, Rolf Wachter, Janka Koschack, et al.. (2010). Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction. Clinical Research in Cardiology. 99(4). 217–226. 27 indexed citations
13.
Norozi, Kambiz, et al.. (2008). Intravenous luteinizing hormone‐releasing hormone has no effect on serum N‐terminal pro‐brain natriuretic peptide in children and adolescents. Pediatrics International. 51(2). 283–288. 4 indexed citations
14.
Wachter, Rolf, Claus Lüers, Christoph Herrmann‐Lingen, et al.. (2007). Impact of Diabetes on Left Ventricular Diastolic Function in Patients with Arterial Hypertension. European Journal of Heart Failure. 9(5). 469–476. 24 indexed citations
15.
Michalsen, Andreas, Nicola T.M. Knoblauch, Nils Lehmann, et al.. (2006). Effects of lifestyle modification on the progression of coronary atherosclerosis, autonomic function, and angina—The role of GNB3 C825T polymorphism. American Heart Journal. 151(4). 870–877. 20 indexed citations
16.
Meyer, Thomas, et al.. (2000). Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. Journal of the American College of Cardiology. 36(5). 1632–1636. 224 indexed citations
17.
Binder, Claudia R., et al.. (1997). Influence of Cycloheximide-Mediated Downregulation of Glucose Transport on TNFα-Induced Apoptosis. Experimental Cell Research. 236(1). 223–230. 14 indexed citations
18.
Niedmann, P. D., et al.. (1997). A Simple and Reliable Reverse-Phase High-Performance Liquid Chromatographic Procedure for Determination of Paclitaxel (Taxol) in Human Serum. Therapeutic Drug Monitoring. 19(3). 327–332. 17 indexed citations
19.
Binder, Claudia R., et al.. (1995). Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variables. Annals of Oncology. 6(10). 1005–1010. 49 indexed citations
20.
Kynast, B., Lutz Binder, D Marx, et al.. (1993). Determination of a fragment of the c-erbB-2 translational product p185 in serum of breast cancer patients. Journal of Cancer Research and Clinical Oncology. 119(5). 249–252. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026